Human Butyrylcholinesterase (aa 199-323) Control Fragment Recombinant Protein

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

protein

product name :

Human Butyrylcholinesterase (aa 199-323) Control Fragment Recombinant Protein

catalog :

RP-100514

quantity :

100 uL

price :

US 259.00

product information

Product Type :

Protein

Product Name :

Human Butyrylcholinesterase (aa 199-323) Control Fragment Recombinant Protein

Catalog # :

RP-100514

Quantity :

100 uL

Price :

US 259.00

Clonality :

Recombinant

Purity :

purified

Reactivity :

Human

Applications :

Blocking Assay: Assay-dependent, Control: Assay-dependent

Species :

Human

Storage :

-20 C, Avoid Freeze/Thaw Cycles

Description :

Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.

Format :

Liquid

Applications w/Dilutions :

Blocking Assay: Assay-dependent, Control: Assay-dependent

Aliases :

acylcholine acylhydrolase; BCHE; BtChE; butylcholinesterase; butyrylcholine esterase; butyrylcholinesterase; C730038G20Rik; CHE1; CHE2; Choline esterase II; cholinesterase; cholinesterase (serum) 2; cholinesterase 1; E1; EC 3.1.1.8; pseudocholinesterase